Prolymphocytic leukemia

Revision as of 20:17, 26 March 2019 by Aditya Ganti (talk | contribs)
Jump to navigation Jump to search

Prolymphocytic leukemia Main page

Patient Information

B-cell prolymphocytic leukemia Patient Information
T-cell prolymphocytic leukemia Patient Information

Overview

Causes

Classification

B-cell prolymphocytic leukemia
B-cell prolymphocytic leukemia

Differentiating B-cell prolymphocytic leukemia from T-cell prolymphocytic leukemia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Carlos A Lopez, M.D. [2], Maria Fernanda Villarreal, M.D. [3]

For more information regarding B-cell prolymphocytic leukemia, please click here.
For more information regarding T-cell prolymphocytic leukemia, please click here.

Overview

Prolymphocytic leukemia is a rare lymphoid leukemia, which account for only about 2% of all mature lymphoid leukemias. Prolymphocytic leukemias present similar to leukemia. Like lymphomas, they originate in the lymphocytes, but do not form solid tumors. Prolymphocytic leukemias are also considered lymphoproliferative disorders, which lymphocytes are produced in large amounts. Prolymphocytic leukemia may be classified according to the type of cell involved: B-cell prolymphocytic leukemia and T-cell prolymphocytic leukemia. Originally, it was thought to be a rare variation of chronic lymphocytic leukemia, but is now considered a distinct disease. It is usually classified as a kind of chronic lymphocytic leukemia. Although these 2 types of prolymphocytic leukemias share some of the same characteristics, the World Health Organization (WHO) classifies them as different types of lymphoid leukemias.[1]

Classification

For more details about each specific type of prolymphocytic leukemia, please select:

 
 
 
 
Prolymphocytic leukemia
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B-cell prolymphocytic leukemia
 
 
 
 
 
T-cell prolymphocytic leukemia

Differentiating B-Prolymphocytic Leukemia from T-Prolymphocytic Leukemia

In order to distinguish B-prolymphocytic leukemia from T-prolymphocytic leukemia, see the table below.

Characteristics B-cell Prolymphocytic Leukemia T-cell Prolymphocytic Leukemia
Epidemiology
  • Rare
  • Very rare
Age
  • 60-70 years
  • 60-70 years
Onset
Clinical Features

B symptoms

Diagnosis Peripheral blood smear
  • Prolymphocytes (90%)

Biomarkers

  • CD20+
Peripheral blood smear

Biomarkers

  • CD52+

Differentiating Prolymphocytic Leukemia from other Leukemias

Differential Diagnosis Surface Immunoglobulin CD5 CD22/FMC7 CD23 CD79b CD103
Prolymphocytic leukaemia Strongly positive Negative Positive Negative Positive Negative
Hairy cell leukaemia Strongly positive Negative Positive Negative Positive/Negative Positive
Chronic lymphocytic leukaemia Weakly positive Positive Negative Positive Negative Positive/Negative
Mantle cell lymphoma Positive Positive Strongly positive Negative Strongly positive Negative
Follicular lymphoma Strongly positive Negative Positive Negative Strongly positive Negative

References

  1. "World Health Organization".


Template:WikiDoc Sources